ACSI Appoints Director of Business Development

Vancouver, BC Canada – (June 11, 2009) – Advanced Cyclotron Systems Inc. (ACSI), the world leading manufacturer of high current cyclotrons, announced today that it has appointed Dr. J. Paul Shea as Director of Business Development.  With more than 20 years experience in executive leadership roles, Dr. Shea is ideally suited to lead ACSI’s business development and marketing team, as well as directly contribute to the company’s overall growth.

“I am excited to have Paul join our team”, said Richard Eppich, CEO and President.  “We were looking for someone with deep, solution-based, business development experience who could lead the expansion of our company.  We are confident that Paul’s track record of success in growing businesses as well his experience in molecular imaging will get us there.  We’re pleased to welcome Paul to our team where he will have a key role in establishing our international presence.”

Dr. Shea joins the ACSI team from Auriga Medical, were he was Vice President and responsible for Auriga’s worldwide business.  Paul has an extensive background in strategic planning, business development and product development in the medical industry.  Dr. Shea was formerly Vice President of Regulatory Affairs at CTI Molecular Imaging and previously Vice President of Clinical Development at PETNET.  Prior to that he managed research and development programs at Molecumetics, Ltd., taking optimized candidate compounds to phase I clinical trials.

“Throughout my career I have worked with pharmaceutical and technological companies that were well positioned in rapidly emerging fields.  With the recent reactor radioisotope shortage, the increasing number of PET centers and new emerging radioisotopes, the cyclotron-produced radioisotope market is poised for record growth.  With the recently released TR-24 and the robust high current TR-19 and TR-30s, ACSI is ideally positioned to play a significant part in this growth. This was an easy decision for me,” said Dr. Shea.  “I’m excited to join the strong team at ACSI and most importantly to help position ACSI as the undisputed technology leader in this rapidly emerging market.”

“When I first contacted Paul for this position, I knew that we have found a perfect match” said Umendra Mital, Vice President and GM of ACSI. “I am looking forward to working with Paul in developing new Customers and new Partnerships.”

About Advanced Cyclotron Systems Inc.

Advanced Cyclotron Systems Inc. is the leading manufacturer of high output cyclotrons for the international nuclear medicine community. ACSI TR series cyclotrons are used for the commercial production and distribution of PET and SPECT radioisotopes by the world’s leading radioisotope producers as well as in leading research facilities. The ACSI TR cyclotron series represent the newest generation of cyclotrons and are the most powerful and versatile commercial cyclotrons in the world.

ACSI’s dedicated team of scientists and engineers design, build and install state-of-the-art cyclotron systems. The advanced technological design and ACSI’s ongoing commitment to research and development make the TR cyclotron systems perfect for today’s needs and tomorrow’s opportunities.


Advanced Cyclotron Systems Inc.


Share This Post

To bookmark this page, press the Ctrl (PCs) or Command (Macs) and D keys on your keyboard.

Email to a Friend:

Return to: Main Blog